Új szemlélet a krónikus myeloid leukaemia diagnosztikájában és terápiájának monitorozásában

Translated title of the contribution: New approach in the diagnosis and monitoring of treatment of chronic myelogenous leukemia

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

The chronic myelogenous leukemia is a pluripotent hemopoetic stem cell disease characterized by the t(9;22) (q34;q11) reciprocal chromosomal translocation (Philadelphia chromosome). The translocation result the fusion of the ABL gene located at the long arm of chromosome 9 with the BCR gene located at the long arm of chromosome 22. The BCR/ABL fusion gene encodes a chimeric protein with elevated tyrosine kinase activity, that plays an important role in the pathogenesis of the disease. In the diagnosis of chronic myelogenous leukemia and in the evaluation of the therapeutic effect, the detection of the t(9;22)(q34;q11) translocation and BCR/ABL fusion gene plays an important role. The authors in the present paper provides a review on the recently used methods of the detection of t(9;22)(q34;q11) chromosomal translocation and BCR/ABL fusion gene and their role in the diagnosis, monitoring and evaluation of therapeutic effect in chronic myelogenous leukemia.

Translated title of the contributionNew approach in the diagnosis and monitoring of treatment of chronic myelogenous leukemia
Original languageHungarian
Pages (from-to)889-895
Number of pages7
JournalOrvosi hetilap
Volume146
Issue number18 SUPPL.1
Publication statusPublished - Dec 1 2005

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'New approach in the diagnosis and monitoring of treatment of chronic myelogenous leukemia'. Together they form a unique fingerprint.

  • Cite this